BACKGROUND: Sustained inflammation in the heart is sufficient to provoke left ventricular dysfunction and left ventricular remodeling. Although inflammation has been linked to many of the biological changes responsible for adverse left ventricular remodeling, the relationship between inflammation and protein quality control in the heart is not well understood.
S
ustained inflammatory signaling in the heart leads to the development of a cardiomyopathy characterized by myocardial fibrosis, left ventricular (LV) dilation, and LV dysfunction. If the inciting cause for the inflammation is resolved (eg, viral myocarditis), the cardiomyopathy is often fully reversible, even though the extent of LV dysfunction may have been severe. Two recent observations suggested the intriguing possibility that impaired protein quality control may play a role in the development of reversible inflammationinduced cardiomyopathy. First, we observed the accumulation of protein aggregates in 2 different transgenic mouse models of sustained inflammation because of myocyte-restricted expression of either TNF (tumor necrosis factor) or TRAF2 (TNF receptor-associated factor 2).
1,2 Interestingly, mice with conditional expression of TRAF2 develop protein aggregates that are subsequently cleared once inflammatory signaling is switched off. 3 Second, bioinformatic analyses of the changes in gene expression in the conditional TRAF2 model suggested that genes involved in the ubiquitin-proteasome system and autophagy, the 2 pathways responsible for protein quality control, were among the most heavily regulated after resolution of inflammatory signaling. 3 Although inflammation plays a well-recognized role in regulating the turnover of proteins in skeletal muscle in the setting of atrophy, the role of inflammation with respect to protein quality control in the heart is less well understood. 4 Accordingly, here we sought to evaluate 2 of the major biological systems involved in the maintenance of protein quality control, namely, the ubiquitin-proteasome and the autophagy-lysosome system in a well-characterized transgenic model of sustained inflammatory signaling (Myh6-sTNF mice) that develops progressive LV remodeling and LV dysfunction. Here, we show for the first time that sustained inflammatory signaling secondary to cardiac restricted overexpression of TNF results in impaired protein quality control secondary to proteasome dysfunction and impaired autophagic flux.
METHODS

Myh6-sTNF Mice
The generation and characterization of the transgenic mouse line with cardiac restricted overexpression of secreted TNF (Myh6-sTNF [previously referred to as MHCsTNF]) used in this study is described elsewhere. 5 Littermate control mice and Myh6-sTNF mice were studied at 4, 8, or 12 weeks of age, as specified. All animal studies were conducted in accordance with the guidelines of the Animal Studies Committee at Washington University School of Medicine and Baylor College of Medicine Animal Care and Research Advisory Committee.
Ubiquitin-Protein Conjugates
Whole hearts from littermate control and Myh6-sTNF mice were harvested, weighed, and then frozen rapidly. Myocardial protein extracts were prepared as described previously, 6 and the aliquots of the supernatants were stored at −80°C. The myocardial protein concentration was determined by the BCA Protein Assay Kit (Pierce, Rockford, IL) using serum albumin as a standard. Equivalent amounts of protein extracts from the littermate control and Myh6-sTNF mouse hearts were separated on a 12% SDS-PAGE under reducing conditions and then transferred to a nitrocellulose membrane in the presence of 0.02% SDS and 25% methanol at 4°C (30 V over 17 hours). The membrane was autoclaved and then blocked in Tris-buffered saline supplemented with 20% heat-inactivated fetal calf serum and 0.45% Tween 20. Western blotting was performed using a rabbit antiubiquitin polyclonal antibody (Affiniti-Research Products Limited, Exeter, UK). The primary antibody was visualized by a horseradish peroxidase (HRP)-labeled secondary antibody and the ECL chemiluminescence assay (both from Amersham Pharmacia Biotech, Piscataway, NJ). The resulting films (HyperfilmTM ECLTM; Amersham Pharmacia) were scanned on a personal densitometer S1 (Molecular Dynamics, Sunnyvale, CA), and band density (in arbitrary units) was evaluated using ImageQuaNT 4.2a (Molecular Dynamics).
Immunofluorescence microscopy was performed on tissue from 12-week-old Myh6-sTNF and littermate control mice using laser confocal microscopy (Zeiss Confocal LSM 700). The tissue was fixed in 4% paraformaldehyde for 24 hours at 4°C and then dehydrated in 70% ethanol. Tissues
WHAT IS NEW?
• This report is the first to link cardiac dysfunction resulting from sustained inflammation to impaired protein turnover.
• We show that this defect in protein quality control entails both proteasome dysfunction and impaired autophagy.
• Although other forms of cardiomyopathy have been linked to impaired protein turnover, our finding that impaired protein turnover contributes to inflammation-induced dysfunction is novel.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Sustained inflammation contributes to left ventricular dysfunction in a wide variety of disease states ranging from chronic heart failure to transient dysfunction observed in the setting of sepsis.
• Various different molecular mechanisms have been shown to contribute to the cardiac dysfunction that develops in response to inflammation. • This report deepens our understanding by showing that impaired protein quality control also plays an important role in this response.
• Moreover, these data suggest that impaired protein quality control may be more widely involved in cardiomyopathy than previously thought.
were embedded in paraffin and cut. Sections were then deparaffinized and rehydrated followed by antigen retrieval using Diva Decloaker solution (Biocare Medical). Slides were blocked in 5% normal donkey serum (Santa Cruz, SC-2044). Primary antibodies were ubiquitin (Abcam, ab134953), p62 (Progen, GP62-C), and desmin (Santa Cruz, sc-7559). Alexa Fluor-conjugated donkey antibodies (Invitrogen) were used as the secondary antibodies.
Proteasome Function
Hearts from Myh6-sTNF and littermate control mice were homogenized in a buffer containing 50 mmol/L Tris-HCl, pH 7.8, 5 mmol/L MgCl 2 , 250 mmol/L sucrose, 2 mmol/L dithiothreitol, and 2 mmol/L ATP, using a 2-mL PYREX tissue grinder. Debris was removed by centrifugation at 10 000g for 15 minutes. The 20S and 26S proteasome were isolated after ultracentrifugations (100 000g for 1 hour and 100 000g for 5 hours), as described by Solomon and Goldberg. Western blot analyses were performed to determine the protein levels of the subunits of the 19S and 20S proteasome using myocardial protein extracts from 12-week-old littermate control and Myh6-sTNF mice. Proteasome subunits were quantified using antibodies from Biomol (Plymouth Meeting, PA).
Autophagy
Whole hearts were harvested from 12-week-old Myh6-sTNF mice and littermate controls. Ventricles were divided into 2 pieces and rapidly frozen in liquid nitrogen and stored at −80°C before isolation of protein and mRNA. Preparation of protein extracts and Western blotting were performed as previously described. 8 The following antibodies were used to assess autophagy substrates: LC3 (Novus Biologicals, NB100-2220), p62 (Abcam, ab56416), GAPDH (Abcam, ab22555), HRP-linked antimouse IgG (Jackson ImmunoResearch, 715-035-150), and HRP-linked antirabbit IgG (Jackson ImmunoResearch, 715-035-152). Band density was determined using Image Station 4000R Pro (Kodak), and Image J software was used for quantitative analysis.
RNA was isolated using Trizol (Ambion) and the PureLink RNA Mini Kit (Invitrogen). cDNA was synthesized using the SuperScript III First-Strand Synthesis System (Invitrogen). Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed on an ABI 7200 machine (Applied Biosystems). Reactions were performed using Power SYBR Green Master Mix (Applied Biosystems). Predesigned primers for SYBR green-based assays were obtained from Integrated DNA Technologies.
To measure autophagic flux, Myh6-sTNF mice and littermate controls were treated with chloroquine (Sigma) 40 mg/kg by IP injection to inhibit lysosome function or equal volume of vehicle (normal saline) 4 hours before euthanasia. Protein extracts were prepared from whole ventricles, and LC3 and GAPDH protein levels were determined by Western blotting as described above.
Lysosome Abundance and Mammalian Target of Rapamycin Complex 1 Activation
Lysosome abundance and mammalian target of rapamycin complex 1 (mTORC1) activation was assessed in tissue harvested from 12-week-old Myh6-sTNF mice and littermate controls by Western blotting and quantitative RT-PCR as described above. Lysosome abundance was assessed by quantifying mRNA and protein levels for the lysosome markers LAMP1 and LAMP2. The following antibodies were used: LAMP1 (Abcam, ab24170), LAMP2 (Developmental Studies Hybridoma Bank, ABL-93), GAPDH (Abcam, ab22555), HRP-linked antirabbit IgG (Jackson ImmunoResearch, 715-035-152), and HRP-linked antirat IgG (Cell Signaling, 7077). Predesigned primers for quantitative RT-PCR were obtained from Integrated DNA Technologies. Cathepsin activity was measured as previously described. 9 Briefly, heart tissue was homogenized in 100 mmol/L sodium acetate, pH 5.5, 2.5 mmol/L EDTA, Triton X-100 0.01%, and 2.5 mmol/L dithiothreitol. For cathepsin B activity, the supernatant was incubated with 100 µmol/L of Z-Arg-Arg-AMC at pH 6.0. For cathepsin D, the supernatant was incubated with 10 µmol/ L/L substrate 7-methoxycoumarin-4-acetyl (Mca)-Gly-Lys-ProIle-Leu-Phe-Phe-ArgLeu-Lys-2,4 nitrophenyl (Dnp)-D-Arg-NH2. The fluorescent intensity of the cleavage products was measured using a TECAN Infinite M200 Pro microplate reader. mTORC1 activation was determined by assessing the ratio of phosphorylated to total protein levels of the downstream targets 4E-BP1 and p70S6K using the following antibodies: phospho-4E-BP1 (Cell Signaling, 9451), total 4E-BP1 (Cell Signaling, 9644), phospho-p70S6K (Cell Signaling, 9234), total p70S6K (Cell Signaling, 9644), and HRP-linked antirabbit IgG (Jackson ImmunoResearch, 715-035-152).
Endoplasmic Reticulum Stress
Endoplasmic reticulum stress was measured in tissue harvested from 12-week-old Myh6-sTNF mice and littermate controls. Western blot was performed as described above using the following antibodies: CCAAT-enhancer-binding protein homologous protein (CHOP; ThermoFisher Scientific, MA1-250), ATF4 (Abcam, ab184909), ATF6 (Cell Signaling, 65880), and Actin (Sigma, A2066). Quantitative RT-PCR for ddit3, sxbp1, and gapdh was performed as described above using predesigned primers from Integrated DNA technologies.
Human Myocardial Samples
Human LV tissue from patients with dilated cardiomyopathy (DCM) that was harvested at the time of cardiac transplant and controls was obtained from the Washington University Translational Cardiovascular Biobank and Repository. Details on the clinical data for these human hearts are summarized in the Data Supplement. The procedures for tissue acquisition have been described previously. 10 Studies were conducted in accordance with protocols approved by the Washington University School of Medicine Institutional Review Board, and all subjects gave informed consent. Immunofluorescent confocal imaging of p62, ubiquitin, and desmin and Western blotting for p62, LC3, and GAPDH were performed as described above.
Statistical Analysis
All data are expressed as mean±SEM. Two-way ANOVA was used to test for mean differences between littermate control and Myh6-sTNF hearts at 4, 8, and 12 weeks of age. Where appropriate, post hoc ANOVA was performed using a Bonferroni analysis. An unpaired Student t test was used to test for mean differences between littermate control and Myh6-sTNF hearts at a single point in time. A difference was said to be significant at the P<0.05 level.
RESULTS
Accumulation of Ubiquitinated Protein Conjugates in Myh6-sTNF Mouse Hearts
We have previously shown that protein aggregates accumulate in the hearts of mice with cardiac restricted overexpression of TNF, as well as mice with cardiac restricted overexpression of TRAF2 that phenocopy the heart failure phenotype observed in the Myh6-sTNF mice. 1, 2 To further assess proteotoxic stress in this setting, we first sought to determine whether there was an accumulation of ubiquitin-tagged proteins in the Myh6-sTNF mouse hearts. Figure 1A depicts a representative Western blot of myocardial samples obtained from littermate control and Myh6-sTNF mice at 12 weeks of age. The salient finding shown by Figure 1A is that the amount of ubiquitin-protein conjugates was greater in Myh6-sTNF hearts when compared with littermate controls. The Western blots of myocardial extracts from mice at 4 and 8 weeks of age showed similar findings; that is, the levels of ubiquitin-protein conjugates were elevated significantly in Myh6-sTNF hearts compared with littermate controls ( Figure 1B) .
To determine the localization of the ubiquitin-tagged proteins, we performed immunofluorescence microscopy in 12-week-old Myh6-sTNF mouse hearts. Confocal imaging demonstrated that the ubiquitinated proteins were incorporated into protein aggregates within individual cardiac myocytes ( Figure 1C ) in Myh6-sTNF mice but were not detectable in wild-type (WT) mice. In other disease processes, protein aggregates have been shown to contain the adaptor protein p62, which binds to ubiquitin-bound proteins and targets them for incorporation into to autophagosomes for subsequent breakdown by the autophagy-lysosome pathway. 11 We found that protein aggregates in our model also contained p62. Indeed, desmin, an intermediate filament protein that plays a critical scaffolding role to link sarcomeres with organelles, 12 that we have previously observed to be cleaved in Myh6-sTNF hearts, 2 colocalizes with p62 and ubiquitin aggregates in cardiac myocytes. We considered that there were at least 3 possible mechanisms for the increased ubiquitin-protein conjugates in the Myh6-sTNF hearts: first, there may have been a decrease in proteasome-mediated degradation of ubiquitin-protein conjugates; second, there could be impaired autophagy; third, there could be an admixture of these mechanisms.
Proteasome Dysfunction in Myh6-sTNF Mouse Hearts
To determine whether alterations in proteasome function might have contributed to the increased ubiquitinprotein conjugates observed in the Myh6-sTNF hearts, we measured chymotrypsin-like activity of the myocardial 26S and the 20S proteasome fractions using an in vitro fluorescent assay. Figure 2A shows that 26S proteasome activity was decreased significantly in the Myh6-sTNF myocardial proteasome fractions when compared with the littermate controls from 4 to 12 weeks of age. However, function of the 20S core subunit was unimpaired through 12 weeks of age ( Figure 2B ure 2B). Interestingly, when we measured expression levels of components of the 19S cap in Myh6-sTNF mouse hearts, we detected the presence of lower molecular weight species of the Rpt4 and Rpn2 subunits, suggesting potential cleavage of Rpt4 and Rpn2. We also detected the presence of a lower molecular weight species of Rpt1 in both the WT and Myh6-sTNF mice. Previous studies have shown that caspase-dependent cleavage of the 19S proteasome can lead to inhibition of the 26S proteasome. 13, 14 Relevant to this discussion, we have previously reported increased activation of caspases 3, 8, and 9 in the Myh6-sTNF mouse hearts. 15, 16 Viewed together, these data suggest (but do not prove) that the impaired function of the 19S cap observed in Myh6-sTNF mice may be related to cleavage of subunits of the 19S cap. To determine whether changes in chymotrypsin-like activity of the 26S subunit were accompanied by compensatory changes in the 20S proteasome subunit of the Myh6-sTNF mice, we also performed Western blot analyses of the 20S proteasome. Figure 2D shows increased expression of various components of the 20S proteasome, suggesting that impairment of the 20S proteasome did not contribute to decreased activity of the 26S proteasome.
Impaired Autophagic Flux in Myh6-sTNF Mouse Hearts
The autophagy-lysosome pathway acts as the back-up protein degradation pathway in the setting of proteasome dysfunction 17 and is primarily responsible for cleavage of a subset of long-lived proteins. 18 The colocalization of p62 with ubiquitin in protein aggregates within cardiac myocytes ( Figure 1C ) suggested the possibility that autophagy was dysregulated in the Myh6-sTNF mouse hearts. To explore this possibility, we examined components of the autophagy-lysosome system. As shown in Figure 3A , there were increased levels of LC3-I, the proteolytically processed form of LC3, and increased levels of LC3-II, the autophagosome-bound form of LC3. The accumulation of LC3-I and LC3-II did not seem to be secondary to increased transcription of LC3, insofar as the amount of mRNA (map1lc3a) was significantly decreased in the Myh6-sTNF mouse hearts ( Figure 3B ), suggesting that the observed changes in LC3-II protein levels were secondary to either increased formation (ie, increased autophagy initiation), impaired clearance (ie, impaired autophagic flux), or a combination of both. We also observed an increase in the amount of p62 protein in Myh6-sTNF mouse hearts when compared with littermate controls (Figure 3A) , consistent with either increased transcription of p62 or impaired consumption of p62 during autophagy. Figure 3B shows that the mRNA levels for p62 (sqstm1) were increased in the 12-week-old Myh6-sTNF mouse hearts, indicating that increased transcription may have contributed to the increase in p62 protein levels.
To determine whether the increased levels of LC3-II and p62 reflected impaired autophagic flux, we treated Myh6-sTNF mice with chloroquine, which inhibits lysosome acidification and fusion with autophagosomes, and then examined LC3-II accumulation in cardiac extracts as an indicator of autophagic flux. 19 As shown in Figure 4A , short-term treatment with chloroquine (for 4 hours) resulted in an expected accumulation of LC3-II (a marker of autophagosome abundance) in littermate control mice, reflecting intact autophagic flux. In contrast, there was no significant change in the levels of LC3-II in the chloroquine-treated Myh6-sTNF mice, suggesting that there was impaired clearance of autophagosomes. Viewed together with the increased levels of LC3-II and p62 in Myh6-sTNF mouse hearts, this suggests that there is impaired autophagic flux.
Mechanisms of Impaired Autophagic Flux in Myh6-sTNF Mouse Hearts
Several mechanisms have been linked to impaired autophagic flux in different cardiovascular disease states, including impaired lysosomal biogenesis 20 and lysosome dysfunction. [21] [22] [23] [24] Accordingly, to address whether lysosomal biogenesis was impaired, we measured levels of LAMP1 and LAMP2 mRNA and protein in the Myh6-sTNF mouse hearts. As shown in Figure 5A , there was a statistically significant increase in the level of lamp1 mRNA and a nonsignificant increase in lamp2 mRNA levels. We also observed a significant increase in LAMP1 and LAMP2 protein levels in the Myh6-sTNF mouse hearts ( Figure 5B ). To characterize lysosome function, we measured lysosomal cathepsin activity. There was no difference in cathepsin B or D activity in lysates from WT littermate and Myh6-sTNF mice ( Figure 5C ). Viewed together, these data suggest that neither decreased lysosome abundance nor impaired lysosome function is responsible for the impaired autophagic flux in the Myh6-sTNF mouse hearts.
Given the central role of mTOR in regulating autophagy, 25 we next examined mTORC1 activity by measuring the phosphorylation of the downstream targets 4E-BP1 and p70S6K. As shown in Figure 5D , there was increased phosphorylation of 4E-BP1 and p70S6K, suggesting that increased mTORC1 activity may have contributed to impaired autophagic flux in the Myh6-sTNF mouse hearts. In addition, we explored whether the observed impaired protein quality control in Myh6-sTNF hearts was accompanied by endoplasmic reticulum stress. As show in Figure I in the Data Supplement, we observed increased protein levels for CHOP, ATF4, and ATF6 protein, as well as increased mRNA expression levels for ddit3 (CHOP) and sxbp1 (the spliced form for Xbp1), consistent with activation of the unfolded protein response.
Impaired Autophagy in DCM
To determine whether the findings observed in the Myh6-sTNF mouse hearts were relevant to human heart failure, we performed immunofluorescence microscopy in hearts obtained from patients with DCM that were obtained at the time of cardiac transplantation. As shown in Figure 6A , we also observed the presence of aggregates containing both ubiquitin-tagged proteins and p62 in the hearts of patients with DCM. We also observed that there were significantly increased levels of both LC3-II and p62 in DCM ( Figure 6B ).
DISCUSSION
The major finding of this study, in which we examined the mechanisms of protein quality control in a transgenic mouse model with cardiac restricted overexpression of TNF (Myh6-sTNF), is that sustained inflammatory signaling leads to the development of proteasome dysfunction and impaired autophagic flux. The following lines of evidence support these statements. First, we observed that there is a striking increase in ubiquitinated protein conjugates in the hearts of the Myh6-sTNF mice (Figure 1) , which was evident as early as 4 weeks of age, before the onset of cardiac remodeling. 5 Moreover, the increase in ubiquitin-protein conjugates was maintained from 8 to 12 weeks of age, at a time period when the Myh6-sTNF mouse hearts have been shown to undergo progressive LV dilation and LV wall thinning. Further, confocal immunofluorescence microscopy demonstrated that ubiquitinated proteins were incorporated into protein aggregates within individual cardiac myocytes in Myh6-sTNF mice but were not detectable in WT mice. Second, we observed proteasome dysfunction, evidenced by decreased chymotrypsin-like activity of the 26S proteasome beginning at 4 weeks of age (Figure 2A and 2B ). The decrease in activity of the 26S proteasome was secondary to dysfunction of the 19S proteasome, insofar as the chymotrypsin-like activity of the 20S proteasome was similar in the littermate controls and Myh6-sTNF mice. Our data suggest, but do not prove, that the dysfunction of the 19S proteasome may be related to cleavage of 19S subunits ( Figure 2C ). Third, there was impaired autophagy in the Myh6-sTNF mouse hearts, leading to an accumulation of autophagy substrates, including increased levels of LC3-II and p62 ( Figure 3A) . Treatment with chloroquine indicated that impaired autophagic flux was responsible for the increased levels LC3-II and p62 (Figure 4 ). Although this study was not intended to delineate the mechanism(s) for impaired autophagy in the Myh6-sTNF mice, we did observe increased mTORC1 activation, a known inhibitor of autophagy, in the Myh6-sTNF mouse hearts ( Figure 5D ). Finally, to determine whether the findings observed in the Myh6-sTNF mouse hearts were relevant to human heart failure, we performed immunofluorescence microscopy in hearts obtained from patients with DCM that were obtained at the time of cardiac transplantation. As shown in Figure 6A , we also observed the presence of aggregates containing both ubiquitin-tagged proteins and p62 in the hearts of patients with DCM, as well as increased levels of both LC3-II and p62 ( Figure 6B) , consistent with what we observed in the Myh6-sTNF mouse hearts. 
Protein Quality Control in DCM
Protein homeostasis, or proteostasis, requires the coordinated action of multiple cellular networks. Under normal conditions, these systems rapidly sense and rectify disturbances in the proteome to maintain tissue homeostasis. During stress, these systems are transiently activated rapidly to preserve protein functionality and cell viability. However, in the setting of chronic stress, the cells' homeostatic mechanisms are insufficient to maintain the proteostasis with the result that damaged proteins cannot be removed resulting in proteotoxicity and cell death. Proteotoxicity is a well-recognized aspect of neurodegenerative diseases. Increasingly, it is also recognized to contribute to a variety of cardiovascular diseases. 26, 27 In the setting of heart failure, proteotoxicity is best recognized as a component of desmin-related cardiomyopathy, and the relevant mechanisms have been studied in a mouse model of the disease. Desmin-related cardiomyopathy results from mutations in either desmin or the chaperone protein alpha-crystallin B chain, which result in protein misfolding, leading to aggregate development, proteotoxicity, and cardiac dysfunction. In this setting in which the proteasome is dysfunctional, augmenting proteolytic activity decreases the accumulation of protein aggregates and delays disease progression. [28] [29] [30] Autophagy plays a protective role in desmin-related cardiomyopathy. 31, 32 In tissue culture, the presence of aggregates provokes an increase in autophagy, 32, 33 which is a protective mechanism to remove cellular debris. 26, 32, 34 However, as the disease progresses, autophagy becomes impaired, which then further contributes to impaired protein turnover and cardiac dysfunction. 26, 31 Alternately, the accumulation of p62 bound to ubiquitinated proteins in cytosolic aggregates may prevent its physiological targeting to the sarcomere, as has been reported previously. 35 Indeed, although we observed that p62 was transcriptionally upregulated, it is possible that this upregulation is insufficient to permit a potential physiological role for p62 because p62 remains sequestered within ubiqutinated protein aggregates in the myocyte.
Although the role of proteotoxicity in desmin-related cardiomyopathy has been well established, the effects of sustained inflammation on protein quality control are less well understood. Previous studies have demonstrated the accumulation of protein aggregates in 2 different transgenic mouse models of sustained activation of the TNF-signaling pathway, 1,2 although the precise mechanisms for these observations have not been determined. Here, we show that there is an accumulation of ubiquitin-tagged proteins early in the disease, which is because of both proteasome dysfunction and impaired autophagic flux. Although our results suggest impaired autophagic flux in the setting of sustained TNF signaling, it should be noted that 2 previous studies have shown that acute stimulation with TNF stimulates autophagy in neonatal rat cardiac myocytes. 8, 36 Thus, the effects of TNF on protein quality control are likely context dependent.
Many mechanisms have been linked to impaired protein quality control in the heart. As noted, our data suggest that the decrease in activity of the 26S proteasome was secondary to a dysfunction of the 19S proteasome, insofar as the chymotrypsin-like activity of the 20S proteasome was similar in the littermate controls and Myh6-sTNF mice, which is consistent with the observations in desmin-related cardiomyopathy. 28, 29 Although activation of mTOR signaling has been demonstrated to inhibit proteasome function in some cell types, the mechanisms remain to be defined. 18 Conceivably, cleavage of the proteasome subunits may be downstream of or synergistic with the effects of mTOR activation in the Myh6-sTNF mice. In the present study, the accumulation of p62 and autophagosomes, as well as the decrease in autophagic flux observed with chloroquine treatment, suggests that there is impaired clearance of autophagosomes in Myh6-sTNF mice, pointing to impaired macroautophagy as a mechanism for the increased accumulation of ubiquitinated proteins. 17, 37 Although impaired lysosome biogenesis and function has previously been linked to decreased autophagy in the setting of ischemia-reperfusion injury and doxorubicin cardiomyopathy, 21, 24 this was not observed in the Myh6-sTNF mouse hearts insofar as neither lysosome abundance nor lysosome function were decreased in Myh6-sTNF mouse hearts. Our data do suggest that activation of mTORC1 may have been one of the mechanisms for the impaired autophagic flux observed in the Myh6-sTNF mice. Although mTOR signaling has been ascribed a critical role in the homeostatic control of nutrient supply and stress responses in the heart, 38 the upstream pathways for mTOR activation in cardiomyopathy remain to be defined and are the focus of active investigation. Viewed together, these results suggest the interesting possibility that inhibiting mTORC1 may improve protein quality control in inflammatory cardiomyopathies.
Conclusions
The results of this study show that sustained inflammatory signaling in the heart leads to the development of proteasome dysfunction and impaired autophagic flux, with the subsequent accumulation of ubiquitinated proteins. The loss of protein homeostasis in the heart may not only lead to proteotoxicity but also be important for a second reason. That is, it is possible that the loss of proteostasis may also contribute to impaired sarcomerogenesis, as well as maintenance of the highly ordered cytoskeletal structures that are required for normal contractility. Indeed, as heart failure advances, there is a gradual loss of sarcomeres (myocytolysis), 39 as well as loss of cytoskeletal elements. 40 During reverse LV remodeling, there is an increase in sarcomerogenesis, as well as restoration of full-length cytoskeletal elements. Interestingly, a recent study in conditional transgenic mouse model that develops reversible DCM showed that resolution of inflammation was accompanied by the clearance of protein aggregates in cardiac myocytes, improved alignment of sarcomeres, and improved contractile function. 3 Germane to this discussion, genes involved in autophagy and the ubiquitin-proteasome system were identified as 2 of the most heavily regulated groups during resolution of the inflammation-induced protein aggregates. Additional studies will be required to determine whether protein quality mechanisms are required for this response.
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